Thomas Matthew Habermann, MD

Professor

  • 19155 Citations
  • 70 h-Index
1978 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Lymphoma, Large B-Cell, Diffuse Medicine & Life Sciences
Non-Hodgkin's Lymphoma Medicine & Life Sciences
Lymphoma Medicine & Life Sciences
Survival Medicine & Life Sciences
Follicular Lymphoma Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
B-Cell Lymphoma Medicine & Life Sciences
Hodgkin Disease Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1978 2017

Lymphoma Specialized Program of Research Excellence

Macon, W. R., Dogan, A. M., Ansell, S. M., Gupta, M. D., Witzig, T. E., Cerhan, J. R., Habermann, T. M., Ratliff, T. L., Link, B. K., Ratliff, T. L., Juweid, M., Ballas, Z., Link, B. K., Ratliff, T., Geyer, S. M., Weiner, G., Lentz, S., Hohl, R. & Smith, B. J.

National Institutes of Health

9/11/026/30/17

Project: Research project

Lymphoma
Non-Hodgkin's Lymphoma
Molecular Epidemiology
B-Lymphocytes
B-Cell Lymphoma

EASTERN COOPERATIVE ONCOLOGY GROUP

Habermann, T. M., Hahn, R. & Edmonson, J.

National Institutes of Health

6/1/784/30/16

Project: Research project

Antineoplastic Protocols
Organized Financing
Neoplasms
Research
Clinical Protocols

Research Output 1983 2019

Cause of death in follicular lymphoma in the first decade of the rituximab era: A pooled analysis of French and US cohorts

Sarkozy, C., Maurer, M. J., Link, B. K., Ghesquieres, H., Nicolas, E., Thompson, C. A., Traverse-Glehen, A., Feldman, A. L., Allmer, C., Slager, S. L., Ansell, S. M., Habermann, T. M., Bachy, E., Cerhan, J. R. & Salles, G., Jan 10 2019, In : Journal of Clinical Oncology. 37, 2, p. 144-152 9 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Cause of Death
Lymphoma
Disease-Free Survival
Rituximab

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study

Wang, Y., Habermann, T. M., Wang, S. S., Maurer, M. J., Sarangi, V., Link, B. K., Feldman, A. L., Inwards, D. J., Witzig, T. E., Cozen, W., Rothman, N., Asmann, Y., Slager, S. L. & Cerhan, J. R., Jan 1 2019, In : American journal of hematology.

Research output: Contribution to journalLetter

Open Access
Mantle-Cell Lymphoma
Tumor Necrosis Factor-alpha
2 Citations (Scopus)

Maintenance rituximab or observation after frontline treatment with bendamustine-rituximab for follicular lymphoma

Hill, B. T., Nastoupil, L., Winter, A. M., Becnel, M. R., Cerhan, J. R., Habermann, T. M., Link, B. K., Maurer, M. J., Fakhri, B., Reddy, P., Smith, S. D., Mukhija, D., Jagadeesh, D., Desai, A., Alderuccio, J. P., Lossos, I. S., Mehra, P., Portell, C. A., Goldman, M. L., Calzada, O. & 9 othersCohen, J. B., Hussain, M. J., Ghosh, N., Caimi, P., Tiutan, T., Martin, P., Kodali, A., Evens, A. M. & Kahl, B. S., Feb 1 2019, In : British Journal of Haematology. 184, 4, p. 524-535 12 p.

Research output: Contribution to journalArticle

Follicular Lymphoma
Maintenance
Observation
Therapeutics
Vincristine
1 Citation (Scopus)

Acute coronary syndromes in patients with active hematologic malignancies – Incidence, management, and outcomes

Park, J. Y., Guo, W., Al-Hijji, M., El Sabbagh, A., Begna, K. H., Habermann, T. M., Witzig, T. E., Lewis, B. R., Lerman, A. & Herrmann, J., Jan 1 2018, (Accepted/In press) In : International Journal of Cardiology.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Acute Coronary Syndrome
Incidence
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Troponin